Morgan Stanley Century Therapeutics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,269,222 shares of IPSC stock, worth $2.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,269,222

Previous 228,613 892.6%

Holding current value

$2.86 Million

Previous $582,000 566.67%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.44 - $3.29 $2.94 Million - $6.71 Million	2,040,609 Added 892.6%	2,269,222 $3.88 Million
Q2 2024 Oct 17, 2024	BUY	$2.46 - $4.05 $35,013 - $57,643	14,233 Added 6.64%	228,613 $582,000
Q2 2024 Aug 14, 2024	BUY	$2.46 - $4.05 $35,013 - $57,643	14,233 Added 6.64%	228,613 $582,000
Q1 2024 Oct 17, 2024	SELL	$3.19 - $5.32 $45,403 - $75,719	-14,233 Reduced 6.23%	214,380 $896,000
Q1 2024 Aug 16, 2024	SELL	$3.19 - $5.32 $209,098 - $348,715	-65,548 Reduced 23.42%	214,380 $896,000
Q1 2024 May 15, 2024	SELL	$3.19 - $5.32 $209,098 - $348,715	-65,548 Reduced 23.42%	214,380 $896,000
Q4 2023 Aug 16, 2024	BUY	$1.28 - $3.32 $65,683 - $170,365	51,315 Added 22.45%	279,928 $929,000
Q4 2023 Feb 13, 2024	SELL	$1.28 - $3.32 $57,062 - $148,005	-44,580 Reduced 13.74%	279,928 $929,000
Q3 2023 Nov 15, 2023	BUY	$2.0 - $3.23 $274,678 - $443,604	137,339 Added 73.38%	324,508 $649,000
Q2 2023 Aug 14, 2023	BUY	$2.91 - $3.53 $392,364 - $475,960	134,833 Added 257.63%	187,169 $591,000
Q1 2023 May 15, 2023	BUY	$3.4 - $5.11 $96,046 - $144,352	28,249 Added 117.28%	52,336 $181,000
Q4 2022 Feb 14, 2023	BUY	$4.84 - $11.58 $27,467 - $65,716	5,675 Added 30.82%	24,087 $123,000
Q3 2022 Nov 14, 2022	SELL	$8.57 - $13.1 $3.36 Million - $5.14 Million	-392,373 Reduced 95.52%	18,412 $182,000
Q2 2022 Oct 27, 2022	BUY	$7.96 - $12.43 $217,172 - $339,127	27,283 Added 7.11%	410,785 $3.45 Million
Q2 2022 Aug 15, 2022	BUY	$7.96 - $12.43 $217,172 - $339,127	27,283 Added 7.11%	410,785 $3.45 Million
Q1 2022 Oct 27, 2022	SELL	$11.62 - $15.92 $317,028 - $434,345	-27,283 Reduced 6.64%	383,502 $4.83 Million
Q1 2022 May 13, 2022	SELL	$11.62 - $15.92 $731,060 - $1 Million	-62,914 Reduced 14.09%	383,502 $4.83 Million
Q4 2021 Feb 14, 2022	BUY	$13.93 - $23.62 $1.6 Million - $2.71 Million	114,547 Added 34.52%	446,416 $7.08 Million
Q3 2021 Nov 15, 2021	BUY	$20.8 - $31.93 $6.9 Million - $10.6 Million	331,869 New	331,869 $8.35 Million

Others Institutions Holding IPSC

# of Institutions

Shares Held

36.9M

Call Options Held

8.7K

Put Options Held

10.2K

View Full List

About Century Therapeutics, Inc.

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $74.2M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

More about IPSC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account